Monthly Archives: October 2015

EC Economic Ef

How can we estimate the separate economic effects of shocks to oil supply and demand? I’ve just finished a research paper with Notre Dame Professor Christiane Baumeister that develops a new approach to this question. The basic reason the question is hard to answer is that we would need to know the value of two key parameters: the response…

EC Savings Glu

Martin Wolf in Thursday’s Financial Times discusses the reasons for low interest rates and suggests some interesting scenarios for the years ahead. I agree with most of what he says but I have doubts about the role that he assigns to central banks. Let me start with the arguments with which I agree 100%. The logic of…

HUI’s Bearish? Engulfing Updated

Well, was the bearish engulfing candle a one day wonder?  Was it too perfect with respect to its predecessor in August?  Did every genius who can look at a chart see it and act upon it?  Well, this genius took a loss on his hedge but also took more miner profits to stay balanced.  That is because…

Canada Goes To The Polls On Monday October 19

Canada’s national election is slated for Monday. The latest opinion polls show a virtual dead heat between the governing Conservatives and Liberals.  Two main issues dominate. The first is the economy. Canada is struggling.  Although the contraction period is over, growth is fragile. The economy contracted for the first five months of the year. Unemployment…

August 2015 Business Sales Decline, Headline Inventories Unchange

Econintersect‘s analysis of final business sales data (retail plus wholesale plus manufacturing) shows unadjusted sales declined compared to the previous month – but there was an improvement of the rolling averages. With inflation adjustments, business sales are in contraction. The inventory-to-sales ratios remain at recessionary levels.   Econintersect Analysis: unadjusted sales rate of growth decelerated 0.7 % month-over-month,…

Roche (RHHBY) To Buy Adheron Therapeutics For $580M

Large pharmaceutical companies are often on the lookout for small strategic acquisitions of companies that have a promising pipeline candidate in their portfolio. Sometimes, acquiring a company with a promising early-stage candidate makes sense instead of developing a product from scratch, which involves a lot of time. Swiss oncology major Roche (RHHBY – Analyst Report)…